<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="366535">
  <stage>Registered</stage>
  <submitdate>14/06/2014</submitdate>
  <approvaldate>30/06/2014</approvaldate>
  <actrnumber>ACTRN12614000688684</actrnumber>
  <trial_identification>
    <studytitle>Treatment of 1-2cm renal stones: a pilot randomised trial comparing shock wave lithotripsy, ureterorenoscopic stone removal and percutaneous nephrolithotomy.</studytitle>
    <scientifictitle>Comparison of stone free-rate following shock wave lithotripsy, ureterorenoscopic stone removal or percutaneous nephrolithotomy in a randomised pilot trial for adult renal stones with a maximum diameter of between 10 and 20 mm</scientifictitle>
    <utrn>U1111-1158-0622</utrn>
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Renal stones</healthcondition>
    <conditioncode>
      <conditioncode1>Surgery</conditioncode1>
      <conditioncode2>Surgical techniques</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Renal and Urogenital</conditioncode1>
      <conditioncode2>Other renal and urogenital disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Shock wave lithotripsy - approximately 3000 shock waves focussed onto stone from an external energy source.   Can be performed without any anaesthetic taking about 50 minutes.
Ureterorenoscopic stone removal - insertion of a fine flexible telescope into the renal tract through the urethra and destruction of stone with a laser.  Requires general anaesthetic and takes about 90 minutes.
Percutaneous nephrolithotomy - creating a tract through the skin to the kidney through which a telescope is inserted, the stone broken up with various energy sources and the fragments removed. Requires a general anaesthetic and takes about 1 hour.
Patients may undergo repeated treatment or offered one of the other alternatives until they are free of stones.</interventions>
    <comparator>There is no consensus on which of these treatments is the best for these patients</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Surgery</interventioncode>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Stone free rate determined using CT scan</outcome>
      <timepoint>4-6 weeks post final treatment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Cost analysis - by way of cost framework derived for previous studies within our unit.  Includes staff, utility, building, drug, equipment and disposable costs.</outcome>
      <timepoint>Post final treatment</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Adult patients.  Renal stones 10-20mm.  </inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>90</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Contraindications to one/all potential treatments.  Pregnant women.  </exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>All patients encountered with inclusion criteria will be invited into trail with information sheet.  If enrolled will be randomly allocated into one of the 3 arms</concealment>
    <sequence>Computer generated randomisation overseen by our statistician who will be "off-site" as a means of allocation concealment.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>Stone free rates will be assessed by a radiologist blinded to the actual treatment</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods>Mixture of parametric and non-parametric analyses depending on data variability.  All statistics to be designed and performed by university affiliated independent statistician</statisticalmethods>
    <masking1>False</masking1>
    <masking2>False</masking2>
    <masking3>True</masking3>
    <masking4>False</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/09/2014</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate>31/03/2015</anticipatedenddate>
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>VIC</recruitmentstate>
    <hospital>Casey Hospital - Berwick</hospital>
    <postcode>3806 - Berwick</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Monash Health</primarysponsorname>
    <primarysponsoraddress>62 Kangan Drive, Berwick, Vic 3806</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Monash Health</fundingname>
      <fundingaddress>62 Kangan Drive, Berwick, Vic 3806</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A randomised pilot study to assess which of the currently used treatments for 10-20mm renal stones provides the best stone free rate</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Not yet submitted</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Monash Health Human Ethics Committee</ethicname>
      <ethicaddress>Monash Medical Centre
246 Clayton Road
Clayton 
Vic 3168</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate>1/08/2014</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mr</title>
      <name>Philip McCahy</name>
      <address>Dept Urology
Casey Hospital
62 Kangan Drive
Berwick
Vic 3806</address>
      <phone>+61 3 87681200</phone>
      <fax />
      <email>philip@seurology.com.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Philip McCahy</name>
      <address>Dept Urology
Casey Hospital
62 Kangan Drive
Berwick
Vic 3806</address>
      <phone>+61 3 87681200</phone>
      <fax />
      <email>Philip.Mccahy@monashhealth.org</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Philip McCahy</name>
      <address>Dept Urology
Casey Hospital
62 Kangan Drive
Berwick
Vic 3806</address>
      <phone>+61 3 87681200</phone>
      <fax />
      <email>Philip.Mccahy@monashhealth.org</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Philip McCahy</name>
      <address>Dept Urology
Casey Hospital
62 Kangan Drive
Berwick
Vic 3806</address>
      <phone>+61 3 8768100</phone>
      <fax />
      <email>Philip.Mccahy@monashhealth.org</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>